Sleep continuity scale in Alzheimer’s disease (SCADS): application in daily clinical practice in an Italian center for dementia

Sleep disorders can occur in many neurodegenerative disorders; in a previous paper we constructed a scale investigating sleep discontinuity/fragmentation with the aim to obtain a rapidly and easily administered tool suitable for early identification and longitudinal monitoring of sleep disturbances...

Full description

Saved in:
Bibliographic Details
Published in:Neurological sciences Vol. 36; no. 3; pp. 469 - 471
Main Authors: Manni, R., Sinforiani, E., Terzaghi, M., Rezzani, C., Zucchella, C.
Format: Journal Article
Language:English
Published: Milan Springer Milan 01-03-2015
Springer Nature B.V
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Sleep disorders can occur in many neurodegenerative disorders; in a previous paper we constructed a scale investigating sleep discontinuity/fragmentation with the aim to obtain a rapidly and easily administered tool suitable for early identification and longitudinal monitoring of sleep disturbances in Alzheimer’s disease (AD). We introduced this instrument in the daily clinical practice in a center for dementia; here we present the results of our experience. Two hundred and sixteen AD outpatients referred to the Alzheimer’s Disease Assessment Unit at the IRCCS C. Mondino National Neurological Institute, Pavia, Italy, in the period October 2012 to March 2014 were administered the scale. The questionnaire global score was correlated with measures of cognitive, functional and behavioral impairment; a significant association was found with Mini-Mental State ( p  = 0.005), Activities of Daily Living ( p  = 0.01), Neuropsychiatric Inventory ( p  = 0.01) and Clinical Dementia Rating ( p  = 0.0005). The present data indicate that the previously validated questionnaire proves to be a suitable, rapid and easy to use tool in investigating sleep quality in AD in daily clinical practice. An early identification and longitudinal monitoring of sleep disturbances in AD may improve pharmacological and non-pharmacological interventions.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1590-1874
1590-3478
DOI:10.1007/s10072-014-1975-2